Is encephalopathy a mechanism to renew sulfate in autism?

Entropy

Volumn 15, Issue 1, 2013, Pages 372-406

  Seneff, Stephanie ^a   Lauritzen, Ann ^b   Davidson, Robert M ^c   Lentz Marino, Laurie ^d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b PhyNet Inc ^*

^c PhyNet Inc   (United States)

^d MOUNT HOLYOKE COLLEGE   (United States)

Author keywords

Aluminum; Ammonia; Autism; Cholesterol sulfate; Encephalitis; Glyphosate; Lead; Mercury; Nitric oxide; Seizures; Taurine

Indexed keywords

EID: 84873180629     PISSN: None     EISSN: 10994300     Source Type: Journal    
DOI: 10.3390/e15010372     Document Type: Review

References (219)

1. Caronna, E.B.; Milunsky, J.M.; Tager-Flusberg, H. Autism spectrum disorders: Clinical and research frontiers. Arch. Dis. Child. 2008, 93, 518-523.
2. Horvath, K.; Papadimitriou, J.C.; Rabsztyn, A.; Drachenberg, C.; Tildon, J.T. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 1999, 135, 559-563.
3. Wakefield, A.J.; Puleston, J.M.; Montgomery, S.M.; Anthony, A.; O'Leary, J.J.; Murch, S.H. Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment. Pharmacol. Ther. 2002, 16, 663-674.
4. Theoharides, T.C.; Doyle, R. Autism, gut-blood-brain barrier, and mast cells. J. Clin. Psychopharm. 2008, 2, 479-483.
5. Theoharides, T.C.; Zhang, B. Hypothesis: Neuro-inflammation, blood-brain barrier, seizures and autism. J. Neuroinflam. 2011, 8, 168.
6. Dettmer, K.; Hanna, D.; Whetstone, P.; Hansen, R.; Hammock, B.D. Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal. Bioanal. Chem. 2007, 388, 1643-1651.
7. Bennetto, L.; Scolding, N. Inflammatory/post-infectious encephalomyelitis. J. Neurol. Neurosurg. Psychiatry 2004, 75, i22-i28.
8. Dalmau, J.; Gleichman, A.J.; Hughes, E.G.; Rossi, J.E.; Peng, X.; Lai, M.; Dessain, S.K.; Rosenfeld, M.R.; Balice-Gordon, R.; Lynch, D.R. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet. Neurol. 2008, 7, 1091-1098.
9. Gable, M.S.; Gavali, S.; Radner, A.; Tilley, D.H.; Lee, B.; Dyner, L.; Collins, A.; Dengel, A.; Dalmau, J.; Glaser, C.A. Anti-NMDA receptor encephalitis: Report of ten cases and comparison with viral encephalitis. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28, 1421-1429.
10. Oller, J.W., Jr.; Oller, S.D.; Oller, S.N. Autism: The Diagnosis, Treatment, & Etiology of the Undeniable Epidemic; Jones & Bartlett Learning: Sudbury, MA, USA, 2010.
11. Vojdani, A.; Pangborn, J.B.; Vojdani, E.; Cooper, E.L. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopath. Ph. 2003, 16, 189-199.
12. Dufault, R.; Schnoll, R.; Lukiw, W.J.; LeBlanc, B.; Cornett, C.; Patrick, L.; Wallinga, D.; Gilbert, S.G.; Crider, R. Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children. Behav. Brain Funct. 2009, 5, 44.
13. Dufault, R.; Lukiw, W.J.; Crider, R.; Schnoll, R.; Wallinga, D.; Deth, R.A. Macroepigenetic approach to identify factors responsible for the autism epidemic in the United States. Clin. Epigenet. 2012, 4, 6.
14. Hartzell, S.; Seneff, S. Impaired sulfate metabolism and epigenetics: Is there a link in autism? Entropy 2012, 14, 1953-1977.
15. Seneff, S.; Davidson, R.M.; Liu, J. Is cholesterol sulfate deficiency a common factor in preeclampsia, autism, and pernicious anemia? Entropy 2012, 14, 2265-2290.
16. Davidson, R.M.; Seneff, S. The initial common pathway of inflammation, disease, and sudden death. Entropy 2012, 14, 1399-1442.
17. Beckham, J.D.; Tyler, K.L. Encephalitis. In Principles and Practice of Infectious Diseases, 7th ed.; Mandell, G.L., Bennett, J.E., Dolin, R., Eds.; Elsevier Churchill Livingstone: Philadelphia, PA, USA, 2009; Chapter 87.
18. Ghaziuddin, M.; Al-Khouri, I.; Ghaziuddin, N. Autistic symptoms following herpes encephalitis. Eur. Child Adolesc Psy. 2002, 11, 142-146.
19. Gilberg, I.C. Onset at age 14 of a typical autistic syndrome: A case report of a girl with herpes simplex encephalitis. J. Autism Dev. Disord. 1986, 16, 369-375.
20. Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: A review. Eur J Pediatr. 2007, 166, 645-654.
21. Seneff, S.; Davidson, R.; Mascitelli, L. Might cholesterol sulfate deficiency contribute to the development of autistic spectrum disorder? Med. Hypotheses 2012, 8, 213-217.
22. Horan, F.E.; Hirsch, F.G.; Wood, L.A.; Wright, L.S. Surface effects on blood-clotting components as determined by Zeta-potentials. J. Clin. Invest. 1950, 29, 202-211.
23. Seneff, S.; Lauritzen, A.; Davidson, R.; Lentz-Marino, L. Is endothelial nitric oxide synthase a moonlighting protein whose day job is cholesterol sulfate synthesis? Implications for cholesterol transport, diabetes and cardiovascular disease. Entropy 2012, 14, 2492-2530.
24. Rosenberg, G.A. Neurological diseases in relation to the blood-brain barrier. J. Cerebr. Blood F. Met. 2012, 32, 1139-1151.
25. Reitsma, S.; Slaaf, D.W.; Vink, H.; van Zandvoort, M.A.M.J.; oude Egbrink, M.G.A. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. Eur. J. Physiol. 2007, 454, 345-359.
26. McCully, K.S. Chemical pathology of homocysteine V: Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases. Ann. Clin. Lab. Sci. 2011, 41, 300-313.
27. Oja, S.S.; Saransaari, P. Taurine as osmoregulator and neuromodulator in the brain. Metab. Brain Dis. 1996, 11, 153-164.
28. Sturman, J.A.; Hepner, G.W.; Hofmann, A.F.; Thomas, P.J. Metabolism of [35S] taurine in man. J. Nutr. 1975, 105, 1206-1214.
29. Schoch, H.J.; Fischer, S.; Marti, H.H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002, 125, 2549-2557.
30. Skowronska, M.; Albrecht, J. Alterations of blood brain barrier function in hyper-ammonemia: An overview. Neurotox. Res. 2012, 21, 236-244.
31. Xaio, H.; Banks, W.A.; Niehoff, M.L.; Morley, J.E. Effect of LPS on the permeability of the blood brain barrier to insulin. Brain Res. 2001, 896, 36-42.
32. Stamatovic, S.M.; Keep, R.F.; Andjelkovic, A.V. Brain endothelial cell-cell junctions: How to open the blood brain barrier. Curr. Neuropharmacol. 2008, 6, 179-192.
33. Huber, J.D.; Egleton, R.D.; Davis, T.P. Molecular physiology and pathophysiology of tight junctions in the bloodbrain barrier. Trends Neurosci. 2001, 24, 719-725.
34. Misra, U.K.; Tan, C.T.; Kalita, J. Seizures in encephalitis. Neurol. Asia 2008, 13, 1-13.
35. Chen, C.-A.; Wang, T.-Y.; Varadharaj, S.; Reyes, L.A.; Hemann, C.; Talukder, M.A.H.; Chen, Y.-R.; Druhan, J.; Zweier, J.L. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010, 468, 1115-1120.
36. Geier, D.A.; Kern, J.K.; Garver, C.R.; Adams, J.B.; Audhya, T.; Nataf, R.; Geier, M.R. Biomarkers of environmental toxicity and susceptibility in autism. J. Neurolog. Sci. 2009, 280, 101-108.
37. James, S.J.; Cutler, P.; Melnyk, S.; Jernigan, S.; Janak, L.; Gaylor, D.W.; Neubrander, J.A. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 2004, 80, 1611-1617.
38. Waring, R.H.; Klovrza, L.V. Sulphur metabolism in autism. J. Nutr. Environ. Med. 2000, 10, 25-32.
39. Finegold, S.M.; Molitoris, D.; Song, Y.; Liu, C.; Vaisanen, M.-L.; Bolte, E.; McTeague, M.; Sandler, R.; Wexler, H.; Marlowe, E.M.; et al. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 2002, 35, S6-S16.
40. Finegold, S.M.; Downes, J.; Summanen, P.H. Microbiology of regressive autism. Anaerobe 2012, 18, 260-262.
41. Finegold, S.M. Desulfovibrio species are potentially important in regressive autism. Med. Hypotheses 2011, 77, 270-274.
42. LaSalle, J.M. A genomic point-of-view on environmental factors influencing the human brain methylome. Epigenetics 2001, 6, 862-869.
43. Deth, R.; Muratore, C.; Benzecry, J.; Power-Charnitsky, V.-A.; Waly, M. How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. Neurotoxicology 2008, 29, 190-201.
44. James, S.J.; Melnyk, S.; Jernigan, S.; Hubanks, A.; Rose, S.; Gaylor, D.W. Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. Autism Dev. Disord. 2008, 38, 1966-1975.
45. Sweeten, T.L.; Posey, D.J.; Shankar, S.S.; McDougle, C.J. High nitric oxide production in autistic disorder: A possible role for interferon-?. Biol. Psychiat. 2004, 55, 434-437.
46. Xu, D.-Z.; Lu, Q.; Deitch, E.A. Nitric oxide directly impairs intestinal barrier function. Shock 2002, 17, 139-145.
47. Mayer, B.; Pfeiffer, S.; Schrammel, A.; Koesling, D.; Schmidt, K.; Brunner, F. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J. Biol. Chem. 1998, 273, 3264-3270.
48. Liu, L.; Hausladen, A.; Zeng, M.; Que, L.; Heitman, J.; Stamler, J.S. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 2001, 410, 490-494.
49. Esko, J.D.; Kimata, K.; Lindahl, U. Proteoglycans and sulfated glycosaminoglycans. In Essentials of Glycobiology, 2nd ed.; Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2009, Chapter 16.
50. Vogl-Willis, C.A.; Edwards, I.J. High-glucose-induced structural changes in the heparan sulfate protegolycan, perlecan, of cultured human aortic endothelial cells. Biochim. Biophys. Acta 2004, 1672, 36-45.
51. Stern, M. Insulin signaling and autism. Front. Endocrinol. 2011, 2, 54.
52. Fumitoshi Irie, F.; Hedieh Badie-Mahdavi, H.; Yamaguchi, Y. Autism-like sociocommunicative deficits and stereotypies in mice lacking heparan sulfate. Proc. Natl. Acad. Sci. USA 2012 109, 5052-5056.
53. Levine, B.; Mizushima, N.; Virgin, H.W. Autophagy in immunity and inflammation. Nature 2011, 469, 323-335.
54. Mizushima, N. Autophagy: Process and function. Gene. Dev. 2007, 21, 2861-2873.
55. Neufeld, E.F. Lysosomal storage diseases. Annu. Rev. Biochem. 1991, 60, 257-280.
56. Valstar, M.J.; Bruggenwirth, H.T.; Olmer, R.; Wevers, R.A.; Verheijen, F.W.; Poorthuis, B.J.; Halley, D.J.; Wijburg, F.A. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. Inherit. Metab. Dis. 2010, 33, 759-767.
57. Mucopolysaccharidoses Fact Sheet. National Institute of Neurological Disorders and Stroke Website. Available online: http://www.ninds.nih.gov/disorders/mucopolysaccharidoses/detail/mucopolysacchari-doses.htm/ (accessed 2 April 2012).
58. Gulbins, E.; Dreschers, S.; Wilker, B.; Grassme, H. Ceramide, membrane rafts and infections. J. Mol. Med. 2004, 82, 357-363.
59. Bengheza, M.; Fauvarque, M.O.; Tournebize, R.; Froquet, R.; Marchetti, A.; Bergeret, E.; Lardy, B.; Klein, G.; Sansonetti, P.; Charette, S.J.; et al. Specific host genes required for the killing of Klebsiella bacteria by phagocytes. Cell Microbiol. 2006, 8, 139-148.
60. Hashimoto, Y.; Orellana, A.; Gil, G.; Hirschberg, C.B. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J. Biol. Chem. 1992, 267, 15744-15750.
61. Moseley, R.; Waddington, R.J.; Embery, G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. BBA-Mol Basis. Dis. 1997, 1362, 221-231.
62. Ross, M.A.; Long, W.F.; Williamson, F.B. Inhibition by heparin of Fe(II)-catalysed free-radical peroxidation of linolenic acid. Biochem. J. 1992, 286, 717-720.
63. Wakefield, A.J. The gut brain axis in childhood developmental disorders. J. Pediatr. Gastr. Nutr. 2002, 34, S14-S17.
64. Norenberg, M.D.; Jayakumar, A.R.; Rama Rao, K.V.; Panickar, K.S. New concepts in the mechanism of ammonia-induced astrocyte swelling. Metab. Brain Dis. 2007, 22, 219-234.
65. Master, S.; Gottstein, J.; Blei, A.T. Cerebral blood flow and the development of ammoniainduced brain edema in rats after portacaval anastomosis. Hepatology 1999, 30, 876-880.
66. Jayakumar, A.R.; Panickar, K.S.; Murthy, C.R.K.; Norenberg, M.D. Oxidative stress and MAPK phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J. Neurosci. 2006, 26, 4774-4784.
67. Oury, T.D.; Piantadosi, C.A.; Crapo, J.D. Cold-induced brain edema in mice: Involvement of extracellular superoxide dismutase and nitric oxide. J. Biol. Chem. 1993, 268, 15394-15398.
68. Brown, G.C.; Borutaite, V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. BBA-Bioenergetics 2004, 1658, 44-49.
69. Alvarez, M.N.; Peluffo, G.; Piacenza, L.; Radi, R. Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: Consequences for oxidative killing and role of microbial peroxiredoxins in infectivity. J. Biol. Chem. 2011, 286, 6627-6640.
70. Poling, J.S.; Frye, R.E.; Shoffner, J.; Zimmerman, A.W. Developmental regression and mitochondrial dysfunction in a child with autism. J. Child Neurol. 2006, 21, 170-172.
71. Good, P. Do salt cravings in children with autistic disorders reveal low blood sodium depleting brain taurine and glutamine? Med. Hypotheses 2011, 77, 1015-1021.
72. Lia, X.; Chauhana, A.; Sheikha, A.M.; Patilb, S.; Chauhana, V.; Lib, X.-M.; Jia, L.; Browna, T.; Malika M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 201, 111-116.
73. Brosnan, J.T.; Man, K.-C.; Hall, D.E.; Colbourne, S.A.; Brosnan, M.E. Interorgan metabolism of amino acids in the streptozotocin-diabetic ketoacidotic rat. Am. J. Physiol. 1983, 244, E151-E158.
74. Brosnan, J.T. Glutamate, at the interface between amino acid and carbohydrate metabolism. Proc. International Symposium on Glutamate, 12-14 October 1998, Bergamo, Italy.
75. Daikhin, Y.; Yudkoff, M. Compartmentation of brain glutamate metabolism in neurons and glia. Proc. International Symposium on Glutamate, 12-14 October 1998, Bergamo, Italy.
76. Schraufstitter, I.U.; Browne, K.; Harris, A.; Hyslop, P.A.; Jackson, J.H.; Quehenberger, O.; Cochrane, C.G. Mechanisms of hypochlorite injury of target cells. J. Clin. Invest. 1990, 85, 554-562.
77. Sutherland, G.R.; Tyson, R.L.; Auer, R.N. Truncation of the Krebs cycle during hypoglycemic coma. Med. Chem. 2008, 4, 379-385.
78. Massieu, L.; Montiel, T.; Robles, G.; Quesada, O. Brain amino acids during hyponatremia in vivo: Clinical observations and experimental studies. Neurochem. Res. 2004, 29, 73-81.
79. Hansen, S.H.; Andersen, M.L.; Cornett, C.; Gradinaru, R.; Grunnet, N. A role for taurine in mitochondrial function. J. Biomed. Sci. 2010, 17, S23-530.
80. Albrecht, J.; Bender, A.S.; Norenberg, M.D. Ammonia stimulates the release of taurine from cultured astrocytes. Brain Res. 1994, 660, 228-232.
81. Albrecht, J. Roles of neuroactive amino acids in ammonia neurotoxicity. J. Neurosci. Res. 1993, 51, 133-138.
82. Foran, E.; Trotti, D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid. Redox Sign. 2009, 11, 1587-1602.
83. Choi, D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 1994, 100, 47-51.
84. Blaylock, R.L.; Strunecka, A. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr. Med. Chem. 2009, 16, 157-170.
85. Monfort, P.; Muñoz, M.-D.; El Ayadi, A.; Kosenko, E.; Felipo, V. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab. Brain Dis. 2002, 17, 237-250.
86. Muñoz, M.D.; Monfort, P.; Gaztelu, J.M.; Felipo, V. Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem. Res. 2000, 25, 437-441.
87. Aguilar, M.A.; Miñarro, J.; Felipo, V. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp. Neurol. 2000, 161, 704-713.
88. Romero-Vives, M.; Barrenechea, C.; Insausti, R.; Felipo, V.; Gaztelu, J.M. Sleep alterations in hepatic encephalopathy could be due to chronic hyperammonemia. J. Sleep Res. 1998, 7, 228.
89. Creten, C.; van der Zwaan, S.; Blankenspoor, R.J.; Maatkamp, A.; van Os, J.; Schieveld, J.N.M. Late onset autism and anti-NMDA-receptor encephalitis. Lancet 2011, 378, 98-99.
90. Rasalam, A.D.; Hailey, H.; Williams, J.H.G.; Moore, S.J. Turnpenny, P.D.; Dean, J.C.S. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev. Med. Child Neurol. 2005, 47, 551-555.
91. Williams, G.; King, J.; Cunningham, M.; Stephan, M.; Kerr, B.; Hersh, J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child Neurol. 2001, 43, 202-206.
92. Wadzinski, J.; Franks, R.; Roane, D.; Bayard, M. Valproate-associated hyperammonemic encephalopathy. JABFM 2007, 20, 499-502.
93. Yehya N.; Saldarini, C.T.; Koski, M.E.; Davanzo, P. Valproate-induced hyperammonemic encephalopathy. Metab. Brain Dis. 2004, 43, 926-927.
94. Rinaldi, T.; Kulangara, K.; Antoniello, K.; Markram, H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc. Natl. Acad. Sci. USA 2007, 104, 13501-13506.
95. Hampton, M.B.; Kettle, A.J.; Winterbourn, C.C. Inside the neutrophil phagosome: Oxidants, myeloperoxidase and bacterial killing. Blood 1998, 92, 3007-3017.
96. Schuller-Levis, G.B.; Park, E. Taurine and Its Chloramine: Modulators of Immunity. Neurochem. Res. 2004, 29, 117-126.
97. Olszowski, S.; Olszowska, E.; Kusior, D.; Szneler, E. Sulphoacetaldehyde as a product of taurine chloramine peroxidation at site of inflammation. Amino Acids 2002, 22, 145-153.
98. Cunningham, C.; Tipton, K.F.; Dixon, H.B.F. Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress. Biochem. J. 1998, 330, 939-945.
99. Ruff, J.; Denger, K.; Cook, A.M. Sulphoacetaldehyde acetyltransferase yields acid phosphate: Purification from Alcaligenes defragrans and gene clusters in taurine degradation. Biochem. J. 2003, 369, 275-285.
100. Johnson, S. The multifaceted and widespread pathology of magnesium deficiency. Med. Hypotheses 2001, 56, 163-170.
101. Strambi, M.; Longini, M.; Hayek, J.; Berni, S.; Macucci, F.; Scalacci, E.; Vezzosi, P. Magnesium profile in autism. Biol. Trace Elem. Res. 2006, 109, 97-104.
102. Mousain-Bosc, M.; Roche, M.; Polge, A.; Pradal-Prat, D.; Rapin, J.; Bali, J.P.; Improvement of neurobehavioural disorders in children supplemented with magnesium-B6. Magnesium Res. 2006, 19, 53-62.
103. Hallak, M.; Berman, R.F.; Irtenkauf, S.M.; Evans, M.I.; Cotton, D.B. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am. J. Obstet. Gynecol. 1992, 167, 1605-1610.
104. Cotton, D.B.; Janusz, C.A.; Berman, R.F. Anticonvulsant effects of magnesium sulfate on hippocampal seizures: Therapeutic implications in preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 1992, 166, 1127-1134.
105. Findling, R.L.; Maxwell, K.; Scotese-Wojtila, L.; Huang, J.;Yamashita, T.; Wiznitzer, M. High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study. J. Autism Dev. Disord. 1997, 27, 467-478.
106. Lelong, E.; Marchetti, A.; Gueho, A.; Lima, W.C.; Sattler, N.; Molmeret, M.; Hagedorn, M.; Soldati, T.; Cosson, P. Role of magnesium and a phagosomal P-type ATPase in intracellular bacterial killing. Cell. Microbiol. 2011, 13, 246-258.
107. Mak, I.T.; Komarov, A.M.; Wagner, T.L.; Stafford, R.E.; Dickens, B.F.; Weglicki, W.B. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss. Am. J. Physiol. 1996, 271, C385-C390.
108. Chai, B.-H.; Zheng, J.-M.; Zhao, Q.; Pollack, G.H. Spectroscopic studies of solutes in aqueous solution. J. Phys. Chem. A 2008, 112, 2242-2247.
109. Pollack, G.H.; Figueroa, X.; Zhao, Q. Review: Molecules, water, and radiant energy: New clues for the origin of life. Int. J. Mol. Sci. 2009, 10, 1419-1429.
110. Chai, B.; Yoo, H.; Pollack, G.H. Effect of Radiant Energy on Near-Surface Water. J. Phys. Chem. B 2009, 113, 13953-13958.
111. Del Giudice, E.; Spinetti, P.R.; Tedeschi, A. Water dynamics at the root of metamorphosis in living organisms. Water 2010, 2, 566-586.
112. Zheng, J.-M.; Chin, W.-C.; Khijniak, E.; Khijniak, E., Jr.; Pollack, G.H. Surfaces and interfacial water: Evidence that hydrophilic surfaces have long-range impact. Adv. Colloid Interface Sci. 2006, 127, 19-27.
113. Guckenberger, R.; Heim, M.; Cevc, G.; Knapp, H.F.; Wiegrbe, W.; Hillebrand, A. Scanning tunneling microscopy of insulators and biological specimens based on lateral conductivity of ultrathin water films. Science 1994, 266, 1538-1540.
114. Markovitch, O.; Chen, H.; Izvekov, S.; Paesani, S.; Voth, G.A.; Agmon, N. Special Pair Dance and Partner Selection: Elementary Steps in Proton Transport in Liquid Water. J. Phys. Chem. B 2008, 112, 9456-9466.
115. Verdel, N.; Jerman, I.; Bukovec, P. The autothixotropic phenomenon of water and its role in proton transfer. Int. J. Mol. Sci. 2011, 12, 7481-7494.
116. Kleinbongard, P.; Schulz, R.; Rassaf, T.; Lauer, T.; Dejam, A.; Jax, T.; Kumara, I.; Gharini, P.; Kabanova, S.; zuyaman, B.O.; et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107, 2943-2951.
117. Li, H.; Raman, C.S.; Glaser, C.B.; Blasko, E.; Young, A.; Parkinson, J.F.; Whitlow, M.; Poulos, T.L. Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. J. Biol. Chem. 1999, 274, 21276-21284.
118. Faber, S.; Zinn, G.M.; Kern. J.C., II; Kingston, H.M.S. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 2009, 14, 171-180.
119. Rohwerder, T.; Sand, W. The sulfane sulfur of persulfides is the actual substrate of the sulfur-oxidizing enzymes from Acidithiobacillus and Acidiphilium spp. Microbiology 2003, 149, 1699-1709.
120. Gratton, J.-P.; Fontana, J.; O'Connor, D.S.; García-Cardeña, G.; McCabe, T.J.; Sessa, W.C. Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. JBC 2000, 275, 22268-22272.
121. Fulton, D.; Gratton, J.-P.; Sessa, W.C. Post-translational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 2001, 299, 818-824.
122. Muñoz, S.; Sebastían, J.L.; Sancho, M.; Martínez, G. Analysis of radiofrequency energy stored in the altered shapes: Stomatocyteechinocyte of human erythrocytes. Bioelectrochemistry 2010, 77, 158-161.
123. Helt, M.; Kelley, E.; Kinsbourne, M.; Pandey, J.; Boorstein, H.; Herbert, M.; Fein, D. Can children with autism recover? If so, how? Neuropsych. Rev. 2008, 18, 339-366.
124. Frosini, M. Changes in CSF composition during heat stress and fever in conscious rabbits. Prog. Brain Res. 2007, 162, 449-457.
125. Fukushima, M.; Mohri, K.; Kataoka, T.; Matsumoto, M. Milli gauss pulsed magnetic field applied phosphate buffered saline solution elevates intracellular Ca2+ level and stimulates phagocytic activity of human neutrophils. Trans. Magn. Soc. Jpn. 2002, 2, 15-18.
126. Barton, M.E.; Klein, B.D.; Wolf, H.H.; White, H.S. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res. 2001, 47, 217-227.
127. Fukushima, M.; Kataoka, T.; Sugiyama, N.; Mohri, K. Milligauss Magnetic Field Applied Pure Water Exert Firefly Luciferin-Luciferase Luminescence and Induce Intracellular Calcium Elevation of CHO Cells Without ATP. IEEE Trans. Magn. 2005, 41, 4188-4190.
128. Kovács, R.; Rabanus, A.; Otáhal, Patzak, A.; Kardos, J.; Albus, K.; Heinemann, U.; Kann, O. Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices. J. Neurosci. 2009, 29, 8565-8577.
129. Fukahori, M.; Itoh, M. Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse. Brain Res. 1990, 529, 16-22.
130. Noseworthy, M.D.; Bray, T.M. Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI. Proc. Soc. Exp. Biol. Med. 2000, 223, 175-182.
131. Rink, L.; Gabriel, P. Extracellular and immunological actions of zinc. BioMetals 2001, 14, 367-383.
132. Murch, S.H.; MacDonald, T.T.; Walker-Smith, J.A.; Levin. M.; Lionetti, P.; Klein, N.J. Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 1993, 341, 711-714.
133. Clayton, T.A. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett. 2012, 586, 956-961.
134. Herrmann, K.M.; Weaver, L.M. The shikimate pathway. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1999, 50, 473-503.
135. Michalowicz, J.; Duda, W. Phenols sources and toxicity. Polish J. Environ. Stud. 2007, 16, 347-362.
136. Shehata, A.A.; Schrödl, W.; Aldin, A.A.; Hafez, H.M.; Kruger, M. The effect of glyphosate on potential pathogens and beneficial members of poultry microbiota in vitro. Curr. Microbiol. 2012, in press.
137. Pothoulakis, C. Effects of Clostridium difficile toxins on epithelial cell barrier. Ann. New York Acad. Sci. 2000, 915, 347-356.
138. Clayton, T.A.; Baker, D.; Lindon, J.C.; Everett, J.R.; Nicholson, J.K. Pharmacometabonomic identification of a significant hostmicrobiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA 2009, 106, 14728-14733.
139. Hoagland R.E. Effects of glyphosate on metabolism of phenolic compounds: VI. Effects of glyphosine and glyphosate metabolites on phenylalanine ammonia-lyase activity, growth, and protein, chlorophyll, and anthocyanin levels in soybean (Glycine max) seedlings. Weed Sci. 1980, 28, 393-400.
140. Duke, S.O.; Hoagland, R.E. Effects of glyphosate on metabolism of phenolic compounds I. Induction of phenylalanine ammonia-lyase activity in dark-grown maize roots. Plant Sci. Lett. 1978, 11, 185-190.
141. Hoyumpa, A.M., Jr. Mechanisms of thiamin deficiency in chronic alcoholism. Am. J. Clin. Nutr. 1980, 33, 2750-2761.
142. Fattal-Valevski, A.; Bloch-Mimouni, A.; Kivity, S.; Heyman, E.; Brezner, A.; Strausberg, R.; Inbar, D.; Kramer, U.; Goldberg-Stern, H. Epilepsy in children with infantile thiamine deficiency. Neurology 2009, 73, 828-833.
143. Watanabe, S.; Yamakura, S.; Hirano, K.; Okumura, Y.; Aiba, H. Case of infantile autism with pediatric Wernicke's encephalopathy due to severe eating disorder (in Japanese). No To Hattatsu. 2009, 41, 43-46.
144. Mattioli, S.; Miglioli, M.; Montagna, P.; Lerro, M.F.; Pilotti, V.; Gozzetti, G. Wernicke's encephalopathy during total parenteral nutrition: observation in one case. J. Parenter. Enteral. Nutr. 1988, 12, 626-627.
145. Moore, J.K.; Braymer, H.D.; Larson, A.D. Isolation of a Pseudomonas sp. which utilizes the phosphonate herbicide glyphosate. Appl. Environ. Microbiol. 1983, 46, 316-320.
146. Siegel, N.; Haug, A. Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochim. Biophys. Acta 1983, 744, 36-45.
147. Tomljenovic, L.; Christopher A. Shaw, C.A. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J. Inorg. Biochem. 2011, 105, 1489-1499.
148. Blaylock, R.L. Aluminum induced immunoexcitotoxicity in neurodevelopmental and neurodegenerative disorders. Curr. Inorg. Chem. 2012, 2, 46-53.
149. Johnson, V.J.; Sharma, R.P. Aluminum disrupts the proinflammatory cytokine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: Possible role in neurodegeneration. Neurotoxicology 2003, 24, 261-268.
150. Nayak, P.; Chatterjee, A.K. Effects of aluminum exposure on brain glutamate and GABA systems: An experimental study in rats. Food Chem. Toxicol. 2001, 39, 1285-1289.
151. Tsunoda, M.; Sharma, R.P. Modulation of tumor necrosis factor alpha expression in mouse brain after exposure to aluminum in drinking water. Arch. Toxicol. 1999, 73, 419-426.
152. El-Rahman, S.S. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol. Res. 2003, 47, 189-194.
153. Bondy, S.C. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 2010, 31, 575-581.
154. Campbell, A.; Becaria, A.; Lahiri, D.K.; Sharman, K.; Bondy, S.C. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J. Neurosci. Res. 2004, 75, 565-572.
155. Mundy, W.R.; Freudenrich, T.M.; Kodavanti, P.R.S. Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures. Mol. Chem. Neuropathol. 1997, 32, 41-57.
156. Oteiza, P.I. A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation. Arch. Biochem. Biophys. 1994, 308, 374-379.
157. Seneff, S.; Davidson, R.M.; Liu, J. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure. Entropy 2012, 14, 2227-2253.
158. Schubert, J.; Riley, E.J.; Tyler, S.A. Combined effects in toxicology--a rapid systematic testing procedure: cadmium, mercury, and lead. J. Toxicol. Environ. Health 1978, 4, 763-776.
159. Heeney, G.M.; Woolf, M.M. Encephalopathy from lead poisoning masquerading as a flu-like syndrome in an autistic child. Pediatr. Emerg. Care 2010, 26, 370-373.
160. Mushak, P.; Davis, J.M.; Crocetti, A.F.; Grant, L.D. Prenatal and postnatal effects of low-level lead exposure: Integrated summary of a report to the U.S. congress on childhood lead poisoning. Environ. Res. 1989, 50, 11-36.
161. Sharifi, A.M.; Baniasadi, S.; Jorjani, M.; Rahimi, F.; Bakhshayesh, M. Investigation of acute lead poisoning on apoptosis in rat hippocampus. Neurosci. Lett. 2002, 329, 45-48.
162. Björck, I.; Granfeldt, Y.; Liljeberg, H. Tovar, J.; Asp, N.-G. Food properties affecting the of carbohydrates, digestion and absorption. Am. J. Clin. Nutr. 1994, 59, 699S-705S.
163. Kaya, M.; Küçük, M.; Bulut Kalayci, R.; Cimen, V.; Gürses, C.; Elmas, I.; Arican, N. Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglycemia in rats Can. J. Physiol. Pharm. 2001, 79, 793-798.
164. Bindra, G.S.; Gibson, R.S.; Thompson L.U. [Phytate][calcium]/[zinc] ratios in Asian immigrant lacto-ovo vegetarian diets and their relationship to zinc nutriture. Nutr. Res. 1986, 6, 475-483.
165. Famularo, G.; De Simone, C.; Pandey, V.; Sahu, A.R.; Minisola, G. Probiotic lactobacilli: an innovative tool to correct the malabsorption syndrome of vegetarians? Med. Hypotheses 2005, 65, 1132-1135.
166. Saes Zobiole, L.H.; de Oliveira, R.S., Jr.; Huber, D.M.; Constantin, J.; de Castro, C.; de Oliveira, F.A.; de Oliveira, A., Jr. Glyphosate reduces shoot concentrations of mineral nutrients in glyphosate-resistant soybeans. Plant Soil 2010, 328, 57-69.
167. Le Bougu ́enec, C.; Schouler, C. Sugar metabolism, an additional virulence factor in enterobacteria. Int. J. Med. Microbiol. 2011, 301, 1-6.
168. Palková, Z.; Vachova, L. Ammonia signaling in yeast colony formation. Int. Rev. Cytol. 2003, 225, 229-272.
169. Nlu, M.; Kupletskaia, M.B.; Bab'eva, I.P.; Egorov, N.S. Phenylalanine ammonia-lyase of pigmented yeasts (in Russian). Mikrobiologiia 1980, 49, 269-273.
170. Burrus, C.J. A biochemical rationale for the interaction between gastrointestinal yeast and autism. Med. Hypotheses 2012, 79, 784-785.
171. Jyonouchi, H.; Geng, L.; Ruby, A.; Reddy, C.; Zimmerman-Bier, B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J. Pediatr. 2005, 146, 605-610.
172. Ashwood, P.; Wills, S.; Van de Water, J. The immune response in autism: A new frontier for autism research. J. Leukoc. Biol. 2006; 80, 1-15.
173. Careaga, M.; van de Water, J.; Paul Ashwood, P. Immune dysfunction in autism: A pathway to treatment. Neurotherapeutics 2010, 7, 283-292.
174. Cummings, J.H.; Macfarlane, G.T. Role of intestinal bacteria in nutrient metabolism. Clin. Nutr. 1997, 16, 3-11.
175. Nicolson, G.L.; Gan, R.; Nicolson, N.L.; Haier, J. Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human Herpes Virus-6 coinfections in the blood of patients with autistic spectrum disorders. J. Neurosci. Res. 2007, 85, 1143-1148.
176. Rasmussen-Lathrop, S.J.; Koshiyama, K.; Phillips, N.; Stephens, R.S. Chlamydia-dependent biosynthesis of a heparan sulphate-like compound in eukaryotic cells. Cell. Microbiol. 2000, 2, 137-144.
177. Bourgeois, C.; Bour, J.B.; Lidholt, K.; Gauthray, C.; Pothier, P. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J. Virol. 1998, 72, 7221-7227.
178. Eichhorn, E.; van der Ploeg, J.R.; Kertesz, M.A.; Leisinger, T. Characterization of a-ketoglutarate-dependent taurine dioxygenase from Escherichia coli. J. Biol. Chem. 1997, 272, 23031-23036.
179. Van der Ploeg, J.R.; Eichhorn, E.; Leisinger, T. Sulfonate-sulfur metabolism and its regulation in Escherichia coli. Arch Microbiol. 2001, 176, 1-8.
180. McCusker, K.P.; Klinman, J.P. Facile synthesis of 1,1-[2h2]-2-methylaminoethane-1-sulfonic acid as a substrate for taurine a-ketoglutarate dioxygenase (TauD). Tetrahedron Lett. 2009, 50, 611-613.
181. Westergaard, N.; Sonnewald, U.; Schousboea, A. Release of -ketoglutarate, malate and succinate from cultured astrocytes: Possible role in amino acid neurotransmitter homeostasis. Neurosci. Lett. 1994, 176, e105-e109.
182. Cook, E.H., Jr.; Leventhal, B.L. The serotonin system in autism. Curr. Opin. Pediatr. 1996, 8, 348-354.
183. Tordjman, S.; Gutknecht, L.; Carlier, M.; Spitz, E.; Antoine, C.; Slama, F.; Carsalade, V.; Cohen, D.J.; Ferrari, P.; Roubertoux, P.L.; et al. Role of the serotonin transporter gene in the behavioral expression of autism. Mol. Psychiatr. 2001, 6, 434-439.
184. Richerson, G.B. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat. Rev. Neurosci. 2004, 5, 449-461.
185. Montagnier, L.; Jamal Aïssa, J.; Ferris, S.; Montagnier, J.-L.; Lavallée, C. Electromagnetic Signals Are Produced by Aqueous Nanostructures Derived from Bacterial DNA Sequences. Interdiscip. Sci. Comput. Life Sci. 2009 1, 89-91.
186. Cauwels, A.; Janssen, B.; Buys, E.; Sips, P.; Brouckaert, P. Anaphylactic shock depends on PI3K and eNOS-derived NO. J. Clin. Invest. 2006, 116, 2244-2251.
187. Selye, H. Stress and disease. The Laryngoscope 1955, 65, 500-514.
188. Kimelberg, H.K.; Goderie, S.K.; Higman, S.; Pang, S.; Waniewski, R.A. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J. Neurosci. 1990, 10, 1583-1591.
189. Viorritto, I.C.B.; Nikolov, N.P.; Siegel, R.M. Autoimmunity versus tolerance: Can dying cells tip the balance? Clin. Immunol. 2007, 122, 125-134.
190. Westall, F.C. Molecular mimicry revisited: Gut bacteria and multiple sclerosis. J. Clin. Microbiol. 2006, 44, 2099-2104.
191. Wills, S.; Cabanlit, M.; Bennett, J.; Ashwood, P.; Amaral, D.G.; van de Water, J. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav. Immun. 2009, 23, 64-74.
192. McEntee, W.J.; Crook, T.H. Glutamate: Its role in learning, memory, and the aging brain. Psychopharmacol 1993, 111, 391-401.
193. Meló, T.M.; Sonnewald, U.; Touret, M.; Nehlig, A. Cortical glutamate metabolism is enhanced in a genetic model of absence epilepsy. J. Cererbr. Blood F. Met. 2006, 26, 1496-1506.
194. Farrell, R.; Ciaran, P.K. Celiac Sprue. N. Engl. J. Med. 2002, 346, 180-188.
195. Vargas, D.L.; Nascimbene, C.; Krishnan, C.; Zimmerman, A.W.; Pardo, C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57, 67-81.
196. Moss, M.; Waring, R.H. The plasma cysteine/sulphate ratio: A possible clinical biomarker. J. Nutr. Environ. Med. 2003, 13, 215-229.
197. Heafield, M.T.; Fearn, S.; Steventon, G.B.; Waring, R.H.; Williams, A.C.; Sturman, S.G. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci. Lett. 1990, 110, 216-220.
198. Ming, X.; Stein, P.; Barnes, V.; Rhodes, N.; Guo, L. Metabolic perturbance in autism spectrum disorders: A metabolomics study. J. Proteome Res. 2012, doi:10.1021/pr300910n.
199. Kent, L.; Emerton, J.; Bhadravathi, V.; Weisblatt, E.; Pasco, G.; Willatt, L.R.; McMahon, R.; Yates, J.R. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J. Med. Genet. 2008, 45, 519-524.
200. Hsueh Y.P.; Sheng, M. Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development. J. Neurosci. 1999, 19, 7415-7425.
201. Ethell, I.M.; Yamaguchi, Y. Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons. J. Cell. Biol. 1999, 144, 575-586.
202. Lauri, S.E.; Kaukinen, S.; Kinnunen, T.; Ylinen, A.; Imai, S.; Kaila, K.; Taira, T.; Rauvala, H. Regulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J. Neurosci. 1999, 19, 1226-1235.
203. DeLong, G.R. Autism, amnesia, hippocampus, and learning. Neurosci. Biobehav. R. 1992, 16, 63-70.
204. Bolton, P.J.; Carcani-Rathwell, I.; Hutton, J.; Sue Goode, S.; Howlin, P.; Rutter, M. Epilepsy in autism: Features and correlates. BJP 2011, 198, 289-294.
205. Gabisa, L.; Pomeroyb, J.; Andriolac, M.R. Autism and epilepsy: Cause, consequence, comorbidity, or coincidence? Epilepsy Behav. Dec. 2005, 7, 652-656.
206. Kunz, W.S.; Kudin, A.P.; Vielhaber, S.; Blmcke, I.; Zuschratter, W.; Schramm, J.; Beck, H.; Elger, C.E. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann. Neurol. 2000, 48, 766-773.
207. Shinohea, A.; Hashimotob, K.; Nakamuraa, K.; Tsujiic, M.; Iwataa, Y.; Tsuchiyaa, K.J.; Sekinea, Y.; Sudaa, S.; Suzukia, K.; Sugiharaa, G.I.; et al. Increased serum levels of glutamate in adult patients with autism. Prog. Neuro. Psychoph. 2006, 30, 1472-1477.
208. Ivanov, A.; Pellegrino, C.; Rama, S.; Dumalska, I.; Salyha, Y.; Ben-Ari, Y.; Medina, I. Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J. Physiol. 2006, 572, 789-798.
209. Tarabeux, J.; Kebir, O.; Gauthier, J.; Hamdan, F.F.; Xiong, L.; Piton, A.; Spiegelman, D.; Henrion, É. Millet, B.; S2D team; et al. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl. Psychiatry 2011, 1, e55.
210. Elder, J.H.; Shankar, M.; Shuster, J.; Theriaque, D.; Burns, S.; Sherrill, L. The gluten-free, casein-free diet in autism: Results of a preliminary double blind clinical trial. J. Autism Dev. Disord. 2006, 36, 413-420.
211. Lonsdale, D.; Shamberger, R.J.; Audhya, T. Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuro. Endocrinol. Lett. 2002, 23, 303-308.
212. Adams, J.B.; Audhya, T.; McDonough-Means, S.; Rubin, R.A.; Quig, D.; Geis, E.; Gehn, E.; Loresto, M.; Mitchell, J.; Atwood, S.; Barnhouse, S.; Lee, W. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011, 11, 111.
213. Aneja, A.; Tierney, E. Autism: The role of cholesterol in treatment. Int. Rev. Psychiatr. 2008, 20, 165-170.
214. Bukelis, I.; Porter, F.D.; Zimmerman, A.W.; Tierney, E. Smith-Lemli-Opitz syndrome and autism spectrum disorder. Am. J. Psychiatry 2007, 164, 1655-1661.
215. Sikora, D.M.; Pettit-Kekel, K.; Penfield, J.; Merkens, L.S.; Steiner, R.D. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. Part A 2006, 140A, 1511-1518.
216. Davis, W. Wheat Belly: Lose the Wheat, Lose the Weight, and Find Your Path Back to Health; Rodale Books: Emmaus, PA, USA, 2011.
217. Grant, W.B.; Cannell, J.J. Autism prevalence in the United States with respect to solar UV-B doses: An ecological study. Dermatoendocrinology 2012, 4, in press.
218. Khalili, H.; Huang, E.S.; Ananthakrishnan, A.N.; Higuchi, L.; Richter, J.M.; Fuchs, C.S.; Chan, A.T. Geographical variation and incidence of inflammatory bowel disease among us women. Gut 2012, 61, 1686-1692.
219. Tomljenovic, L; Shaw, C.A. Aluminum vaccine adjuvants: Are they safe? Curr. Med. Chem. 2011, 18, 2630-2637.